​When we talk about research, we are referring to the act of investigating and the main objective of the research of expanding knowledge.
When you think about a research project, you think about how to carry it out, the materials you need, and the time it requires.
 
Although there are many types of research, and iPLACENTA is made up of many different kinds of research projects, today I want to tell you about clinical research, in which the patient is the protagonist, and talk about: how we recruit patients.

​It is important to note that not everyone knows what the research is about and how much work it requires.

Being able to shelter a baby inside the womb for 9 months is something I have always found fascinating. Not only is it a beautiful result of natural adaptation, but pregnancy is also a risky situation during which an efficient compromise needs to be reached between the baby, who needs the mother’s resources, and the mother who needs to cope with the huge challenge of transforming her own body for the benefit of her baby. Maintaining this equilibrium would be impossible without the placenta, which performs an impressive number of tasks to keep both the baby and the mother safe from fecundation to birth. And yet, the placenta has never really received the attention it deserves. Not only by the general public, which often only has vague ideas about what a placenta does, but even more sadly, by the scientific community. The placenta is the least studied organ of the human body and still holds many mysteries. I wasn’t too sure myself about what a placenta did exactly before starting my PhD. I have to say that since then, I have never stopped being amazed at its multi-faceted capacities. With this article, I would like to put the placenta under the spotlight for a moment by sharing with you some of what I found are its most astonishing powers.

   

​Veronica Giorgione is studying the long-term effects of preeclampsia on the cardiovascular system. In her job, she meets and counsels mothers who have just had preeclampsia. Here is a summary of the advice she usually gives:

In these difficult times, when we are surrounded with sad news coming from all over the world and especially Italy (where I am currently completing my PhD) which has been one of the countries most affected by the pandemic, it is difficult to stay positive and see the silvering of the current situation. Many of us can agree that completing a PhD under normal circumstances is stressful, so what happens when la dolce vita takes a drastic turn and your research becomes affected in a new and unfamiliar way? Well, actually the answer I hear the most often, is that no one actually knows. So instead of worrying about things that are out of our control and focusing on the negative aspects of navigating the uncertain waters of work and life and that sunny holiday everyone had seem to be planning being cancelled, I would like to share the good things happening right now all around us. 
​

​This issue of our Science Untangled will focus on how we can use molecular biology to understand more about disease. In iPLACENTA we are interested in the causes of pregnancy pathologies; the juice of the matter is really to understand what's different between a healthy placenta and an unhealthy placenta that will cause the mother to develop a disease, putting both mother and baby in danger. 

​

This video was recently published as an entry in the "Dance Your PhD" contest that is run by Science magazine. The goal of the competition is to explain science with dance. Camilla Soragni and Gwenaëlle Rabussier joined up with their fellow MSCA early-stage researchers at Mimetas, the organ-on-chip company, to explain - through dance - the basic concepts underlying their research: "From 2D Cell Culture to Vascularized Organ".

​“Hi, my name is Mirren and I’m…” a project manager for an EU-funded project called iPLACENTA.

​I should really relearn the sentence, because most of the time people don’t know what that means. What usually follows is that I explain what iPLACENTA is about: it’s a training network of 15 PhD students with quite different backgrounds and approaches who do research on the placenta and placental disease. But how do I go on? 

Introduction
​
When people think about PhDs they directly think about academia. And rightly so, a PhD is by definition a “title conferred by the highest university degree” (Britannica, 2019). Just like any degree, a PhD is directly linked to the institution that confers the title regardless of whether the project is developed in institutions outside the academic environment. However, nowadays there exist scholarship schemes which require the involvement of partners unrelated to academia. An example of such is our iPLACENTA project which is part of the Marie Sklodowska-Curie Actions (MSCA) Innovative Training Networks (ITN). Innovative Training Networks foster the collaboration of beneficiaries (institutions which host PhD students) from academia as well as the non-academic sector (in iPLACENTA’s case: universities, clinical research institutions and industry). Even if ITNs have been around since 2014 [1], not many people know about this interdisciplinary form of PhD.   ​

As we are both enrolled in this type of PhD, this blog is an opportunity to share our personal experiences of Early Stage Researchers in the private sector, and, specifically, what it means to be one at Mimetas. Chapter after chapter, we will explore the life-enriching experience that is doing a Ph.D. outside the academic world.